an individual has to think about their and their familys health over the course of their entire life)
Patients should expect multiple generic versions to become available from different manufacturers
Weight loss can change body proportions, which might make some people perceive differences but that doesnt mean the drug causes physical enlargement
"The data from every clinical trial, regardless of outcome, is vital to accelerating our understanding of this disease and helps inform the next generation of clinical trials
Who It's For (Based on Trial Inclusion Criteria) BMI 30 (obesity) OR BMI 27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, high cholesterol, sleep apnea) Adults ages 1875 (some trials include narrower age ranges) People who have tried lifestyle interventions (diet and exercise) without sufficient weight loss Those with type 2 diabetes seeking both glucose control and weight loss People with obesity-related conditions that would improve with major weight reduction Who Should Avoid Retatrutide Based on trial exclusion criteria and the drug's mechanism, retatrutide is likely not appropriate for: Pregnancy or breastfeeding: Not studied in these populations
The injection should never be administered too low or too close to the center of the buttock, as this may increase the risk of contacting the sciatic nerve or nearby blood vessels